Biomoda Inc. Moves to Assure Commercialization with Triangulum Contract.

ALBUQUERQUE, N.M. -- Outsourcing to Accelerate Company's Entry into Commercial Cancer Detection and Treatment

Biomoda Inc. has contracted with Triangulum Consulting Services Inc. (www.trianguluminc.com) headquartered in Raleigh, N.C. to provide guidance with regulatory approvals and to accelerate "time to market" for Biomoda's patented products primarily involved with early detection and targeted treatment of specific cancers.

Triangulum, formerly JASA Consulting Services, LLC., is widely recognized as a leading provider of consulting services in biopharmaceutical and related fields. After a review of the technologies employed and patents held by Biomoda, Triangulum is prepared to commit significant resources to enable Biomoda to efficiently and cost-effectively complete the regulatory steps and bring Biomoda's critically needed products to market quickly.

Biomoda Inc., a development stage in-vitro diagnostics organization, is focused on research, development and commercialization of cancer diagnostics. The company, exclusive worldwide licensee from the University of California of several patents developed for noninvasive early detection and treatment of lung cancer, is in the process of registering additional patents in this area. The company's proprietary technologies provide minimally invasive and minimal impact approaches as cancer diagnostic products. Operating from its laboratory situated at Kirtland Air Force Base (Albuquerque, N.M.), the company is in the process of expanding and expediting its product development and commercialization with a number of strategic alliances that will be announced over the next 60 days.

This news release contains forward-looking statements that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q. For additional information, visit the Biomoda Web site at www.biomoda.com or call us at 505-821-0875.